Skip to main content
OpenTrials
Completed

NCT Number: NCT03075761

Physical Activity in Children at Risk of Post-thrombotic Sequelae (PACT)

'The PACT trial' is randomized pilot trial to demonstrate the feasibility and potential effectiveness of a personal "fitness tracker" to improve adherence to an activity regimen following an initial acute DVT in children.

Completed

Looking for future studies?

Notify Me

Key information

Age range

7 year–21 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Medical Center

Dallas, Texas, 75235, United States

About this study

The feasibility of an innovative intervention of a validated fitness tracker, the Fitbit, to improve adherence to a 12-week activity regimen in a pilot randomized controlled trial (RCT) will be tested in 44 subjects with first, acute, proximal lower extremity deep vein thrombosis (DVT).

The primary outcomes will consist of a) feasibility indicators determined a priori (eligibility, consent, adherence, retention) and b) estimates of effect size associated with the prescribed activity regimen, by describing within-subject change in QoL and potential biomarkers of postthrombotic syndrome (PTS) pre and post intervention in each group.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A radiologically confirmed, acute, proximal first lower extremity DVT
  • 4 to 8 weeks after starting anticoagulation
  • Out-patient ambulatory status

Exclusion criteria

  • Contraindication to increasing activity such as patients with juvenile arthritis, poor balance, congestive heart failure, etc.

Treatment and study plan

Fitbit

Device

The Fitbit will be utilized in the intervention arm to improve adherence to a 12-week activity regimen.

Other names: Activity tracker

30-minute education session

Behavioral

Primary outcomes

  1. Feasibility as Measured by Number of Participants Who Meet Study Eligibility Criteria at Baseline

    Time frame: Baseline

    Feasibility criteria for rate of study eligibility met when assessed to be ≥ 30%

    Inclusion criteria

    1.) Age 7-21 years 2.)2. A radiologically confirmed, acute, proximal (iliofemoral and femoropopliteal) first lower extremity DVT and/or confirmed, acute pulmonary embolism (unilateral or bilateral) 3.) 12 weeks (±2 weeks) after starting anticoagulation 4.) Out-patient ambulatory status

  2. Number of Screened Subjects Who Provided Consent at Baseline

    Time frame: Baseline

    Feasibility criteria for rate of consent was assessed to be ≥ 30% at baseline

    Inclusion criteria

    1.) Age 7-21 years 2.)2. A radiologically confirmed, acute, proximal (iliofemoral and femoropopliteal) first lower extremity DVT and/or confirmed, acute pulmonary embolism (unilateral or bilateral) 3.) 12 weeks (±2 weeks) after starting anticoagulation 4.) Out-patient ambulatory status

  3. Mean Number of Participants Who Adhered to the Assigned Physical Activity During 8-week Period (Intervention Arm -FitBit Arm )

    Time frame: 8 weeks

    Adherence in the physical activity group is calculated based on the number of participants who complied with the target weekly goal or activity prescription during the "active" 8-week period.

  4. Mean Physical Activity Questionnaire Score at 3 Months (Standard of Care Arm Only)

    Time frame: 3 months

    The Godin-Shephard Leisure-Time Physical Activity Questionnaire was used to quantify physical activity levels. Individuals reporting moderate-to-strenuous activity levels ≥24 were classified as active (better outcome), whereas individuals reporting moderate-to-strenuous activity levels ≤23 were classified were insufficiently active (worse outcome).

  5. Mean Physical Activity Questionnaire Score at 6 Months (Standard of Care Arm Only)

    Time frame: 6 months

    The Godin-Shephard Leisure-Time Physical Activity Questionnaire was used to quantify physical activity levels. Individuals reporting moderate-to-strenuous activity levels ≥24 were classified as active (better outcome), whereas individuals reporting moderate-to-strenuous activity levels ≤23 were classified were insufficiently active (worse outcome).

  6. Mean Physical Activity Questionnaire Score at 9 Months (Standard of Care Arm Only)

    Time frame: 9 months

    The Godin-Shephard Leisure-Time Physical Activity Questionnaire was used to quantify physical activity levels. Individuals reporting moderate-to-strenuous activity levels ≥24 were classified as active (better outcome), whereas individuals reporting moderate-to-strenuous activity levels ≤23 were classified were insufficiently active (worse outcome).

  7. Proportion of Subjects Who Complete Post-randomization

    Time frame: Within 24 months of trial initiation

    Feasibility criteria is met when assessed to be ≥ 80%. This includes the number of subjects who successfully completed the trial.

Secondary outcomes

  1. Change in PTS Biomarkers (D-dimer)

    Time frame: From baseline to 6 months

    Change in PTS biomarkers from baseline to post intervention of increased physical activity measured by coagulation activation marker D-dimer.

  2. Percentage Change From Baseline in FVIII PTS Biomarker

    Time frame: From baseline to 6 month

    Change in PTS biomarkers from baseline to post intervention of increased physical activity measured by the coagulation activation marker FVIII

  3. Change in PTS Biomarkers (C-reactive Protein)

    Time frame: From baseline to 6 month

    Change in PTS biomarkers from baseline to post intervention of increased physical activity measured by inflammation marker C-reactive protein (CRP) using a latex-enhanced immunoturbidimetric assay.

  4. Change in PTS Biomarkers (Fibrinolysis - Endogenous Thrombin Potential)

    Time frame: From baseline to 6 month

    Change in PTS biomarkers from baseline to post intervention of increased physical activity measured by endogenous thrombin potential using calibrated automated thrombogram (CAT). CAT is a routine test that measures hyper- and hypocoagulability.

  5. Change in PTS Biomarkers (Fibrinolysis - Thrombin Generation)

    Time frame: From baseline to 6 month

    Change in PTS biomarkers from baseline to post intervention of increased physical activity measured by thrombin generation assay using calibrated automated thrombogram (CAT). CAT is a routine test that measures hyper- and hypocoagulability.

  6. Percent Change in Fibrinolysis Biomarker

    Time frame: From baseline to 6 month

    Percent Change in Fibrinolysis Biomarker from baseline to post intervention of increased physical activity is measured by thromboelastography (TEG). TEG is often used to predict bleeding and diagnose various bleeding disorders.

    Lysis 30% and Lysis 60% are measurements of percent amplitude reduction 30 and 60 minutes after maximum amplitude, respectively, on thromboelastography.

    Decreased clotting ability (negative value) = better outcome Increased clotting ability (positive value)= worse outcome

  7. Change in Quality of Life

    Time frame: From baseline to 6 months

    Change in Quality of Life from baseline to post intervention of increased physical activity assessed by PedsQL instrument. It consists of structured interview with the parents and the child with 23 items divided among 4 sub-scales to assess function in 4 domains: Physical; Emotional; social; and School. Each item is a statement of a problem, which the subject rates in severity from 0-4, indicating a problem never occurs (score of 0) to almost always occurs (score of 4). Items are reversed scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50,3=25,4=0, with higher scores indicating better health related QoL.

    The positive change from baseline to 6 months correspond to better quality of life.

Sponsors and collaborators

Lead sponsor

University of Texas Southwestern Medical Center

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)
  • Texas Scottish Rite Hospital for Children

Registry information

Official study title

Physical Activity in Children at Risk of Post-thrombotic Sequelae: A Pilot Randomized Controlled Trial

Acronym: PACT

Important dates

Study start
2016
Primary completion
2019
Study completion
2019
First posted
Mar 9, 2017
Registry last updated
May 18, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.